chr7-80745029-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM2BP4_StrongBP6_Very_StrongBP7
The NM_006379.5(SEMA3C):āc.2121A>Gā(p.Gln707=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00199 in 1,614,064 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0010 ( 0 hom., cov: 33)
Exomes š: 0.0021 ( 0 hom. )
Consequence
SEMA3C
NM_006379.5 synonymous
NM_006379.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.540
Genes affected
SEMA3C (HGNC:10725): (semaphorin 3C) This gene encodes a secreted glycoprotein that belongs to the semaphorin class 3 family of neuronal guidance cues. The encoded protein contains an N-terminal sema domain, integrin and immunoglobulin-like domains, and a C-terminal basic domain. Homodimerization and proteolytic cleavage of the C-terminal propeptide are necessary for the function of the encoded protein. It binds a neuropilin co-receptor before forming a heterotrimeric complex with an associated plexin. An increase in the expression of this gene correlates with an increase in cancer cell invasion and adhesion. Naturally occurring mutations in this gene are associated with Hirschsprung disease. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 7-80745029-T-C is Benign according to our data. Variant chr7-80745029-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 783002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.54 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SEMA3C | NM_006379.5 | c.2121A>G | p.Gln707= | synonymous_variant | 18/18 | ENST00000265361.8 | NP_006370.1 | |
SEMA3C | NM_001350120.2 | c.2175A>G | p.Gln725= | synonymous_variant | 18/18 | NP_001337049.1 | ||
SEMA3C | NM_001350121.2 | c.1947A>G | p.Gln649= | synonymous_variant | 19/19 | NP_001337050.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SEMA3C | ENST00000265361.8 | c.2121A>G | p.Gln707= | synonymous_variant | 18/18 | 1 | NM_006379.5 | ENSP00000265361 | P1 | |
SEMA3C | ENST00000419255.6 | c.2121A>G | p.Gln707= | synonymous_variant | 18/18 | 2 | ENSP00000411193 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00101 AC: 153AN: 152200Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
153
AN:
152200
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000816 AC: 205AN: 251160Hom.: 0 AF XY: 0.000811 AC XY: 110AN XY: 135710
GnomAD3 exomes
AF:
AC:
205
AN:
251160
Hom.:
AF XY:
AC XY:
110
AN XY:
135710
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00210 AC: 3063AN: 1461746Hom.: 0 Cov.: 69 AF XY: 0.00203 AC XY: 1474AN XY: 727180
GnomAD4 exome
AF:
AC:
3063
AN:
1461746
Hom.:
Cov.:
69
AF XY:
AC XY:
1474
AN XY:
727180
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00100 AC: 153AN: 152318Hom.: 0 Cov.: 33 AF XY: 0.000765 AC XY: 57AN XY: 74484
GnomAD4 genome
AF:
AC:
153
AN:
152318
Hom.:
Cov.:
33
AF XY:
AC XY:
57
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
SEMA3C-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 21, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at